ABSTRACT Background: It has been reported that deviations in gut microbiota composition may predispose toward obesity, and specific groups of commensal gut bacteria may harvest energy from food more efficiently than others. Alterations in microbiota compositions of mothers may be transferred to infants and lead to an increased risk of overweight. Objective: We analyzed the fecal microbiota composition of infants of overweight and normal-weight mothers and assessed the relations of weight and excessive weight gain of mothers during pregnancy on the microbiota of infants. Design: Mothers (n = 16) whose prepregnancy body mass index (BMI; in kg/m 2 ) was 25 were selected with their infants from a prospective follow-up study of 256 women. Women with a BMI ,25 (n = 26) and their infants served as control subjects. At the ages of 1 and 6 mo, infant stool samples were available for the analysis of microbiota composition by fluorescence in situ hybridization combined with flow cytometry and quantitative real-time polymerase chain reaction. Results: Infants' fecal microbial composition was related to the weight and weight gain of their mothers during pregnancy. Fecal Bacteroides and Staphylococcus concentrations were significantly higher in infants of overweight mothers during the first 6 mo. Higher weights and BMIs of mothers were related to higher concentrations of Bacteroides, Clostridium, and Staphylococcus and lower concentrations of the Bifidobacterium group. Prevalences of Akkermansia muciniphila, Staphylococcus, and Clostridium difficile groups were lower in infants of normal-weight mothers and of mothers with normal weight gains during pregnancy. Conclusion: The composition and development of infant gut microbiota are influenced by BMI, weight, and weight gain of mothers during pregnancy.
INTRODUCTION
Overweight and obesity are among the major current health problems and are increasing rapidly in industrialized countries. Obesity is associated with a heightened risk of comorbidities such as type 2 diabetes and cardiovascular diseases. The commensal intestinal microbiota influences human health by affecting nutrient use, enhancing gut-barrier function, and stimulating immune development. Deviations from healthy breastfed infant microbiota are associated with a higher risk of allergic and inflammatory conditions and obesity (1, 2) . The Bacteroides group was suggested to harvest energy from food more efficiently than commensal gut microbes (3) . Lean humans have more bacteroidestype bacteria, whereas obese subjects have more Firmicutes in their intestinal microbiota (3, 4) . Furthermore, animal studies show the involvement of the gut microbiota in fat storage by different mechanisms (3) (4) (5) . More polysaccharides are metabolized and the products absorbed from the gut, lipogenic enzymes, are activated in the liver to convert them into triglycerides, which, in turn, are efficiently taken up and stored in adipose tissue through simultaneous microbial suppression of fasting-induced adipose factor, which is a lipoprotein lipase inhibitor.
Previous results from our group showed that overweight pregnant women had more Bacteroides-Prevotella group bacteria than normal-weight pregnant women (6) . The numbers of these bacteria increased as the women gained weight during pregnancy. It has been reported that the mother is an important source of intestinal bacteria for the infant, and the current aim was to evaluate the effects of the prepregnancy weight of mothers and weight gain during pregnancy on infant microbiota acquisition and development during the first 6 mo of life.
SUBJECTS AND METHODS

Design and subjects
Mothers were selected from an ongoing prospective follow-up study of 256 women that started in April 2002 (NCT00167700, section 3; http://www.clinicaltrials.gov) (7) . Women were eligible for participation during the first weeks of gestation (,17 wk of pregnancy) provided that they had no metabolic or chronic diseases such as diabetes; allergy was an allowed condition. The exclusion criterion of the study was related to metabolic or chronic diseases. The study complied with the Declaration of Helsinki, as revised in 2000. Written informed consent was obtained from participants, and the study protocol was approved by the Ethics Committee of the Hospital District of South-West Finland.
For the purpose of the current study, mothers were selected according to the prepregnancy body mass index (BMI) calculated as weight in kilograms divided by the square of height in meters. A total of 42 women (ie, 16 overweight women with a BMI (in kg/m 2 ) 25, and 26 normal-weight women with a BMI ,25) were included in this study. Heights of mothers were measured at the first visit, and prepregnancy weights were taken from well-women clinic documents where the self-reported prepregnancy weights were recorded during the first visit. After delivery and at 1 and 6 mo, data and results of a clinical examination of the infants were obtained during study visits. Stool samples from 16 infants from overweight and obese mothers (BMI 25) and 26 infants from normal-weight mothers with a prepregnancy BMI of 18-25 were available for microbiota analyses.
To analyze the effect of the weight gains of mothers during pregnancy on infant microbiota, weight gains were classified according to the Institute of Medicine (8) recommendations as normal weight gains of 11.5-16.0 kg for normal-weight women (prepregnancy BMI of 19.8-25) and 7.0-11.5 kg for overweight women (BMI 25). Total weight gains over these values of .16 and .11.5 kg for normal-weight and overweight mothers, respectively, were considered excessive weight gains.
Microbiota analyses
Infant fecal samples at 1 and 6 mo of age were weighed, diluted 10 times in phosphate-buffered saline (PBS), homogenized thoroughly with glass beads, and centrifuged (2000 · g, 2 min, 4°C) to remove debris. Aliquots of supernatant fluid were taken for DNA extraction and to fix cells for fluorescence in situ hybridization combined with flow cytometry (FCM-FISH) analysis.
A QIAamp DNA Stool Mini Kit (Qiagen, Hilden, Germany) was used to extract DNA from pure cultures of the different microorganisms and fecal samples by following the manufacturer's instructions. For FCM-FISH, cells were fixed with fresh 4% paraformaldehyde (1:3 vol:vol) at 4°C overnight. After fixation, the samples were centrifuged at 22,000 · g for 5 min and washed with PBS. The washing and centrifuging were repeated 3 times, and the samples were stored in 1:1 ethanol-PBS at 220°C until analysis.
FCM-FISH
The bacterial group-or genus-specific eubacterial 16S ribosomal RNA-targeted probes used in this study included the Bifidobacterium genus (Bif164), Bacteroides-Prevotella group (Bac303), and Clostridium histolyticum group (CHis150) previously used (6) . Probes were labeled at the 5# end with indocyanine (Cy3; MOLBIOL, Berlin, Germany). For determination of total bacterial counts, an EUB 338 specific probe for the domain bacteria labeled with fluorescein isothiocyanate (FITC) was used. Each group-specific Cy3 probe was combined with the EUB 338-FITC probe to determine specific cell numbers. Samples were hybridized as previously described (6) . Briefly, each fluorescent probe (50 ng/lL) was added to aliquots of a fixed cell suspension and incubated in hybridization buffer (10 mmol/L tris-HCl, 0.9 M NaCl, and 10% sodium dodecyl sulfate) at probe-specific temperatures overnight. Hybridized cells were washed with hybridization buffer without sodium dodecyl sulfate, centrifuged (9500 · g for 5 min) and resuspended in PBS. Flow-cytometric analyses were performed on 96-well plates with a BD LSR II flow cytometer (Becton, Dickinson, and Co, Franklin Lakes, NJ) equipped with a high-throughput sampler and a 488-nm laser at 15 mW. Data were stored as list-mode files and analyzed offline with BD FACSDiva software version 5.0.3 (Becton, Dickinson, and Co). Results were expressed as numbers of cells hybridizing with both the specific group-Cy3 probe and the total bacteria EUB 338-FITC probe.
Quantitative real-time polymerase chain reaction
The polymerase chain reaction (PCR) primers used for characterization of fecal microbiota in this study included the Bifidobacterium genus group and species, including B. longum, B. breve, B. bifidum, B. adolescentis and B. catenulatum (6, 9) , Bacteroides fragilis group (10), Clostridium coccoides (10), Cl. leptum (11), Cl. perfringens (12), Cl. difficile (13), Staphylococcus aureus (14) , and Akkermansia muciniphila (15) . These oligonucleotides were purchased from the Thermo Electron Corporation (Thermo Biosciences, Ulm, Germany). Quantitative real-time PCRs (qPCRs) were conducted as previously described (6) . qPCR amplification and detection were performed with an ABI PRISM 7300-PCR sequence detection system (Applied Biosystems, Foster City, CA). Each reaction mixture of 25 lL was composed of SYBR Green PCR Master Mix (Applied Biosystems), 0.5 lL of each of the specific primers at a concentration of 0.2 lmol/L, and 1 lL template DNA. Fluorescent products were detected in the last step of each cycle. A meltingcurve analysis was made after amplification to distinguish targeted from nontargeted PCR products.
The bacterial concentration in each sample was calculated by comparing the threshold values (Ct) obtained from standard curves. These curves were created by using a serial 10-fold dilution of pure culture DNA that corresponded to 10 2 to 10 9 genome equivalents/mL. The conversion of the amount of bacterial DNA in samples measured by qPCR to theoretical genome equivalents required the assumption that the genome size and 16S ribosomal RNA gene copy number for each of the bacteria were similar. Genome sizes were obtained from the National Center for Biotechnology Information (NCBI) database (www. ncbi.nlm.nih.gov/sites/genome).
Statistical analyses
Statistical analyses were conducted with SPSS 11.0 software (SPSS Inc, Chicago, IL). Data distributions were analyzed by applying the Kolmogorov-Smirnov test. Because of nonnormal distribution, microbial data are expressed as medians with interquartile ranges. The Mann-Whitney U test was applied for comparisons between bacterial numbers in normal and overweight women and also between women with excessive and normal weight gains during pregnancy. Differences in prevalences of bacterial groups were analyzed by logistic regression models for each time point and, in some cases, by the generalized estimation equation (GEE) for early development from birth to 6 mo old. Correlations between variables were determined by applying Spearman's rank correlation. P , 0.050 was considered statistically significant for all tests.
RESULTS
Clinical characteristics of infants and mothers
Clinical characteristics of the infants and their mothers were similar between groups as defined by the women's overweight status ( Table 1 ) with obvious differences in BMIs and weights of mothers before pregnancy. All mothers were in good health; most women were expecting their first child. Infants of overweight women had significantly higher weights at birth than did those of normal-weight women (P = 0.021).
Infants' fecal microbiota composition according to mothers' prepregnancy BMI
The weights and BMIs of mothers before pregnancy had an effect on infant microbiota composition during early life. By using the FISH-FCM technique, significantly lower numbers of Bacteroides-Prevotella-group bacteria (P = 0.040) at 1 mo of age and higher numbers of the C. histolyticum group (P = 0.020) at 6 mo of age were observed in infants of overweight mothers than in those of normal-weight mothers ( Table 2) . Similarly, significantly lower numbers of Bacteroides-Prevotella-group bacteria (P = 0.027) at 1 mo of age and higher numbers of the C. histolyticum group (P = 0.023) at 6 mo of age were observed in infants of mothers with excessive weight gains than in infants of mothers with normal weight gains ( Table 3 ). In addition, significant correlations were detected between prepregnancy body weights and weights before pregnancy and numbers of Bacteroides and C. histolyticum. Higher prepregnancy weights of mothers were associated with lower concentrations of Bacteroides in infants at 1 mo of age (r = 20.35, P = 0.028) and higher concentrations of C. histolyticum in infants at 6 mo of age (r = 0.36, P = 0.017). Bifidobacterium-group concentrations in infants from normal-weight mothers were not different from those in infants of overweight mothers [9.28 (8.98-9 .43) compared with 8.93 (8.44-9.54) log cells/g, P = 0.217 at 1 mo of age; and 8.50 (7.67-8.70) compared with 8.43 (7.98-8.70) log cells/g, P = 0.492 at 6 mo of age].
Bacterial numbers detected by qPCR are shown in Table 4 . Bifidobacterium-group counts were higher in infants from normal-weight mothers than in infants from overweight mothers at 6 mo of age (P = 0.008), although no differences were observed in the first month of life (P = 0.232). No differences in the composition of bifidobacterial species were detected. Higher concentrations of C. leptum (P = 0.040) and lower concentrations of C. perfringens (P = 0.050) were detected in 6 mo-old infants of overweight mothers.
Taking into account samples with quantified bacterial concentrations, significant correlations were detected between BMI and microbial concentrations at 6 mo for Bifidobacterium (r = 20.40, P = 0.007) and Staphylococcus (r = 0.77, P , 0.0001). Higher concentrations of Bifidobacterium were observed in infants from normal-weight women, whereas a reverse trend was observed for Staphylococcus. Results were similar at 6 mo for weight before pregnancy (r = 20.30 and P = 0.050 for Bifidobacterium and r = 0.55 and P = 0.004 for Staphylococcus).
A. muciniphila was detected more frequently in infants of overweight women than in infants of normal-weight women This observation was also confirmed when the early microbiota development in infants from 1 to 6 mo of age was evaluated (GEE OR: 7.59, P = 0.001, 95% CI: 2.37, 24.29). Staphylococcus 1 Values are medians of cell numbers per gram of fecal sample; interquartile ranges in parentheses. All analyzed samples showed positive signal. Prevalence was 100% for all cases. n, number of samples analyzed. Microbial data at 1 and 6 mo were analyzed by using ANOVA for repeated measures, where the factors were maternal BMI group (overweight compared with normal weight) and time.
2 Statistical differences were calculated by using Mann-Whitney U test. P , 0.05 was considered significant. 3 In this case, significant differences were found (P = 0.009) by ANOVA for repeated measures comparing BMI (in kg/m 2 ) 25 and BMI ,25 samples during infancy. ) ,25 and .11.5 kg in women with BMI 25 was considered excessive. All analyzed samples showed positive signal. Prevalence was 100% for all cases. n, number of samples analyzed.
2 Statistical differences were calculated by using Mann-Whitney U test. P , 0.05 was considered significant.
aureus was more prevalent in infants at 1 mo of age of overweight mother [8/16 (50%)] than in infants at 1 mo of age of normalweight mothers [6/26 (28%)], although no significant differences were shown. In logistic regression analysis, the prevalences of S. aureus in infants of overweight mothers compared with in infants of normal-weight women were not significantly different (OR: 2.57, P = 0.158, 95% CI: 0.70, 9.55 at 1 mo and OR: 0.77, P = 0.681, 95% CI: 0.23, 2.63 at 6 mo).
Compositional Bifidobacterium species differences in feces were observed between infants of overweight and normalweight mothers. B. adolescentis prevalences were significantly lower in infants of normal-weight women [1/26 (8%) and 6/26 (18.5%) for 1-and 6-mo-old infants, respectively) than in infants of overweight women [5/16 (18.8%]) and 13/16 (47.1%) for 1-and 6-mo-old infants, respectively]. Infants from obese mothers had higher numbers of B. adolescentis than did infants from normal-weight women (logistic regression OR: 2.65, P = 0.318, 95% CI: 0.39, 18.00 at 1 mo and logistic regression OR: 3.91, P = 0.049, 95% CI 1.00, 15.25 at 6 mo). This tendency was also confirmed during early microbiota development in infants from 1 to 6 mo of age (GEE OR: 3.22, P = 0.024, 95% CI: 1. 16, 8.92) . No significant differences were detected in the other bacterial prevalence groups between normal-weight and overweight women.
Infant microbiota composition according to weight gains of mothers during pregnancy
Weight gains of mothers during pregnancy had an effect on infant microbiota composition during the first 6 mo. Lower numbers of Bacteroides-Prevotella-group bacteria at 1 mo of age (P = 0.027) and higher concentrations of the C. histolyticum group at 6 mo of age (P = 0.023) as assessed by FCM-FISH were observed in infants of mothers with excessive weight gains during pregnancy (Table 3 ). In addition, higher weight gains of mothers during pregnancy were associated with lower concentrations of Bacteroides (r = 20.35, P = 0.025) and higher concentrations of C. histolyticum (r = 0.37, P = 0.021) in infants at 1 mo of age. A similar trend was shown for both bacterial groups in infants at 6 mo of age, but no significant differences were observed. No significant differences were observed in concentrations of 1-mo-old infant microbiota analyzed by qPCR, whereas 6-mo-old infants of mothers with excessive weight gains showed lower bifidobacterial concentrations ( Table  5) . Lower concentrations of Bifidobacterium (r = 20.301, P = 0.047) and higher concentrations of Staphylococcus aureus (r = 0.467, P = 0.017) at the age of 6 mo were observed in infants of excessive weight-gain mothers. Infants of mothers with excessive weight gains during pregnancy showed a tendency toward a higher proportion of A. muciniphila in feces than did infants of mothers with normal weight gains at 1 mo of age [8/22 (36. 4%)] and 3/20 (15.0%), respectively; P = 0.095] but not at 6 mo of age [11/22 (50.0%) and 5/20 (24%), respectively; P = 0.105]. An enhanced presence of C. difficile in infants during early life was related to mothers with excessive weight gains during pregnancy. C. difficile prevalences were lower (P = 0.193 and P = 0.046 for infants aged 1 and 6 mo) in infants of normal weight-gain mothers than in those of mothers with excessive weight gains. In addition, the Staphylococcus aureus group was detected more frequently in infants of mothers with excessive weight gains during pregnancy [(at 1 mo of age (P = 0.048) but not at 6 mo of age (P = 0.800)].
Infant microbiota composition according to infant weight
Higher infant weight during the first months of life was related to higher concentrations of the C. coccoides group (r = 0.300 and P = 0.051 at 6 mo of age). In addition, a higher ratio of Bifidobacterium to the C. coccoides group was also associated with lower infant weight at 6 mo of age (r = 20.272, P = 0.070). Thus, high numbers of bifidobacteria were associated with lower infant weight and higher numbers of clostridia were associated with higher infant weight. No differences were shown between microbiota composition and weight at birth and 1 mo of age.
DISCUSSION
Our study showed that weights of mothers have an effect on infant microbiota development. The composition and activity of the intestinal microbiota are important for gut-barrier development, but they are also considered to be involved in host energy homoeostasis (16) . Recent findings showed a link in animal models between immune-system malfunction, microbial alterations, and increased appetite (17) . In the current study, we report, for the first time to our knowledge, that the weights, weight gains during pregnancy, and microbiota compositions of mothers affected the microbiota development in infants, which suggested that the microbiota of mothers is an important factor for infant health.
Bifidobacteria form the predominant microbiota in breast-fed infants and are hypothesized to affect weight gain through mucosal host-microbe crosstalk, immune regulation, and control of inflammation (18) . We previously showed that Bifidobacteriumgroup concentrations were higher in normal compared with overweight women during pregnancy (6). Our results attested that infants from women with normal weight gains during pregnancy show higher concentrations of bifidobacteria than did infants of women with excessive weight gains, which suggested a potential role of the Bifidobacterium group in infant microbiota and weight development. In addition, higher infant weight during early infancy is linked to lower numbers of bifidobacteria. More rapid increases in weight-for-length measurements during the first 6 mo of life are associated with an increased risk of obesity at 3 y of age; changes in weight status in infancy may influence the risk of later obesity more than weight status at birth (19) . One recent study reported that high numbers of bifidobacteria may correlate positively with the normalization of inflammatory status and improved glucose tolerance and glucose-induced insulin secretion (20) . These findings, together with our current results, suggest that higher numbers of bifidobacteria are associated with the normalization of inflammatory processes and, thus, support the hypothesis of a modulating role of bifidobacteria within the intestinal microbiota. Because the Bifidobacterium species have been envisaged as key biological markers of a healthy gut, it is important to further analyze the composition of the bifidobacterial species. Differences in the composition of Bifidobacterium species have been related to inflammatory diseases such as allergies, metabolic disorders, and obesity (21) (22) (23) , and different immunomodulatory properties have been attributed to specific bifidobacteria (24) . B. adolescentis has been associated with inflammatory effects, whereas B. longum and B. bifidum were shown to have balancing immunoregulatory properties (25, 26) . The results of the current study suggested differences in the composition of infant Bifidobacterium species according to the BMIs and weight gains of mothers during pregnancy. Although we only detected significant differences in Bifidobacterium-group concentrations, the species composition also varied. Particularly the species typical of adult-type microbiota composition could favor Th2-biased immune responses that are characteristic of allergy inflammation (27) . In addition, because the higher BMIs of mothers correlated with lower ratios of Bifidobacterium to C. coccoides, the proportion of C. coccoides were higher than the proportion of Bifidobacterium concentrations. The ratio of the Bifidobacterium to the C. coccoides group was significantly higher in infants of normal-weight women than in infants of overweight women at 6 mo of age, whereas no differences were detected at 1 mo of age. A significant reduction in this ratio was also evident in children who later developed atopic diseases, which indicated that the relative proportions of these bacterial groups may precede the development of immune-related disorders (21) . It has been reported that Bifidobacterium concentrations were lower in allergic infants, whereas other groups, such as Staphylococcus, had higher concentrations compared with those in healthy infants (28) . Our recent case-control study showed that the microbiota composition in infancy may predict overweight later in childhood; overweight children had lower numbers of the genus Bifidobacterium spp. and higher numbers of Staphylococcus aureus in their stools during infancy (1) . In a recent study, the weight and BMI of mothers before pregnancy correlated with higher concentrations of Staphylococcus (6). Higher concentrations of the Staphylococcus group were detected in infants of overweight women and women with excessive weight gains during early infancy. The results suggested the potential role of the Staphylococcus group in weight-gain development. In addition, it has also been suggested that higher concentrations of Staphylococcus are associated with inflammatory diseases (2, 29, 30) . Several studies have reported the potential involvement of mucin-degrading bacteria such as A. muciniphila (Verrucomicrobium group) in the pathogenesis of inflammatory diseases (31, 32) . Our data showed a high prevalence of A. muciniphila in infants of obese and excessive weight-gain mothers. According to our previous studies, A. muciniphila numbers were significantly higher in overweight than in normal-weight women, which suggested a link between obesity, overweight, and microbiota (6, 33) . In animal models, higher concentrations of Akkermansia have also been associated with allergic diarrhoea, whereas lower concentrations were associated with diets with lower allergic symptoms, fasting, and hibernation in mice (34, 35) . Previous studies suggested that colonization with C. difficile early in life is more common in infants who develop an allergic disease than in infants who do not (36) (37) (38) . Another work reported that allergic infants had higher concentrations of isocaproic acid, which has been associated with a marked presence of C. difficile, than did healthy infants (39) . C. difficile analysis indicated that the prevalence was significantly higher in infants from overweight and excessive weight-gain women. C. difficile may be regarded as a target in weight development because it has been associated with the development of allergy and intestinal disorders (37, 40) .
In the current study, we report that lower concentrations of the Bacteroides group and higher concentrations of Clostridium in infants during early life may be related to the excessive weight gains of mothers during pregnancy, which is in keeping with the results of previous studies in obese and lean subjects (1, 4, 16) . It has been proposed that such bacterial composition can lead to improved extraction of additional energy from ingested food, which results in enhanced energy storage and is also related to inflammatory processes (3, 16) . Furthermore, differences in Bacteroides concentrations in mothers during pregnancy were related to lower concentrations of the Bacteroides and Bifidobacterium groups and higher concentrations of Staphylococcus aureus in infants at 1 mo of age. Thus, the association between Bacteroides-group concentrations in mothers and their effect on microbiota alterations related to obesity development appears clear and should be taken into account in future interventions. Our results showed the presence of high numbers of clostridia (Firmicutes) in infants of overweight women, which confirmed that previous results on adults (3, 4) may also be transferred to infants. A tendency was observed in infants of mothers with normal weight gains that showed higher concentrations of clostridia (belonging to the C. coccoides and C. leptum groups) than in infants of mothers with excessive weight gains during pregnancy. The C. histolyticum group was analyzed as representative of Firmicutes phyla, and this group was present in significantly higher counts in infants from obese women and women with excessive weight gains during pregnancy, which is in accord with previous reports (3) (4) (5) (6) .
Taken together, our findings showed that the mothers' weights have an effect on microbiota acquisition, composition, and activity during early infancy. Differences in the composition of infant fecal microbiota are associated with the prepregnancy BMI and weight gain of mothers during pregnancy. Higher concentrations of Bifidobacterium during infancy may provide protection against overweight and obesity development. However, higher concentrations of A. muciniphila may indicate an increase in the degradation of intestinal mucin and increased microbial access to the epithelial cells, thereby influencing the proinflammatory activity. Particularly, the Bacteroides, Clostridium, and Staphylococcus groups were altered, and high concentrations of these groups may predispose individuals to enhanced energy storage and obesity and decreased control of the systemic low-grade inflammation typical of obesity. Understanding the reported changes may facilitate new studies in microbiota modulation in efforts to avoid overweight development.
